Revenue

As pet anxiety soars, a new partnership brings a clinically proven adaptogen to the dog supplement market, setting a new standard for evidence-based care.

A recent scientific review links low glutathione to brain disease. A new supplement claims to solve the delivery problem. Is this the future of cognitive health?

Clean-tech innovator FuelPositive faces scrutiny for delaying its AGM, raising questions about governance as it races to revolutionize farming with green ammonia.

Lush Life Hospitality Group opens Bull Moose, an ultra-discreet 12-seat members' lounge hidden in Oyster Bay, signaling a new trend in suburban luxury.

With its key earnings call on March 12, Aemetis's recent tax credit sales and project milestones are weighed against past financial performance.

With Apple's durable new iPhone 17e on the market, Socket Mobile’s latest scanning solutions are turning the popular smartphone into a powerhouse for warehouses.

As consumers report growing subscription fatigue, one meal delivery service is ditching the auto-ship model. Is this the future of convenient dining?

Western Alliance Bank accuses Jefferies of fraud over a loan tied to the bankrupt First Brands Group, exposing a multi-billion dollar scheme.

A new program offers free egg freezing to donors, promising empowerment. But as the fertility market booms, it raises complex ethical questions.

Blade Outboards' new Halo Connect app brings real-time data, GPS security, and over-the-air updates to its electric motors, aiming to redefine the standard.

Sutherland's new Agentic AI platform promises to scale automation across finance, but can its 'Responsible AI' blueprint conquer regulatory hurdles?

The influencer-founded brand brings its 'Ayurvedistry™' philosophy to Sephora U.S., marking a milestone for Indian beauty's mainstream ascent.

Alpha Modus resolves its patent lawsuit against Brookshire Grocery, highlighting an aggressive IP strategy in the booming AI retail technology sector.

As cyber threats escalate, TSplus Advanced Security v7.5 delivers a multi-layered defense for Windows servers, targeting ransomware before it strikes.

GreenArrow's acquisition of The Narwhal Group and key leadership hires signal a bold strategy to consolidate the booming intelligent transportation market.

Allarity Therapeutics lands a crucial $20M debt deal to push its unique ovarian cancer drug, stenoparib, through late-stage trials and extend its runway to 2028.

AIRO Group will present its future vision at a major tech conference, facing investor scrutiny amid ambitious growth plans and recent financial hurdles.

Brazilian aerospace giant Embraer shatters financial records and builds its largest-ever order book, signaling a robust recovery in global aviation.

Propelled by its teen-focused Journeys brand, the footwear retailer posted strong profits, navigating mixed results in other divisions and setting a path for 2027.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.